PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit and follow @PacBio.MENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 PM PT (7:30 PM ET) in San Francisco, California.
加利福尼亞州門羅公園，2025年1月2日（全球新聞網絡）-- PacBio（納斯達克: PACB），一家領先的高質量、高精度測序解決方案開發商，今天宣佈管理層將在2025年1月14日星期二下午4:30（太平洋時間）在加利福尼亞州舊金山舉行的第43屆年度摩根大通醫療健康會議上進行演講。
A live webcast of the event can be accessed at the company's investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
您可以通過公司的投資者頁面 investor.pacificbiosciences.com 訪問本次活動的直播網絡廣播。活動結束後，網絡廣播的回放將在至少30天內提供。
About PacBio
關於PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit and follow @PacBio.
PacBio（納斯達克: PACB）是一家領先的生命科學科技公司，設計、開發和製造先進的測序解決方案，幫助科學家和臨牀研究人員解決遺傳複雜問題。我們的產品和技術源自兩種高度差異化的核心技術，專注於準確性、質量和完整性，包括我們的HiFi長讀測序和SBb短讀測序技術。我們的產品涵蓋廣泛的研究應用，包括人類生殖系測序、植物與動物科學、傳染病與微生物學、腫瘤學以及其他新興應用。欲獲取更多信息，請訪問並關注@PacBio。
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
PacBio產品僅供研究使用。不可用於診斷程序。
Contacts
聯繫人
Investors:
Todd Friedman
ir@pacb.com
投資者：
託德·弗裏德曼
ir@pacb.com
Media:
pr@pacb.com
媒體：
pr@pacb.com
